Latest news for Nuix (OTC:NXLLF) Stock

Nuix Ltd is engaged in providing software-related services. It is engaged in the development and distribution of software. The company offers services to advisory firms, litigation support vendors, corporations, government, and law enforcement agencies. Its products include Nuix Discover, Nuix Investigate, and Nuix Workstation. The group's revenue mainly consists of license fees from customers' right to use the software. Its customers are located in Asia Pacific, the Americas, Europe, the Middle East, and Africa.

Nuix Ltd

WIIM

PAHC

Phibro Animal Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance.

Mach Natural Resources shares are trading lower after the company announced an offering of 12,903,226 shares.

AMTD

AMTD Digital shares are trading higher after the company announced a partnership with Alibaba Pictures Culture for firm, entertainment, and fashion.

Thornburg Investment Management is spreading its roots in the ETF space with the launch of two <a href="https://www.benzinga.com/etfs">actively managed bond funds</a>.
The Thornburg Core Plus Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPLS#NYSE">TPLS</a>) and the Thornburg Multi Sector Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMB#NYSE">TMB</a>) aim to provide investors with diversified bond market exposure through strategic, active management.
The latest launches build on Thornburg's growing ETF footprint. Just last month, the firm <a href="https://www.benzinga.com/25/01/43200794/thornburgs-etf-debut-first-funds-target-global-equities-with-active-strategies">introduced its first two actively managed ETFs</a>, the Thornburg International Equity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXUE#NASDAQ">TXUE</a>) and the Thornburg International Growth ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXUG#NASDAQ">TXUG</a>). These funds have already attracted more than $80 million in investments.
Also Read: <a href="https://www.benzinga.com/25/02/43537127/cohen-steers-expands-active-etf-offerings-with-three-new-funds">Cohen &amp; Steers Expands Active ETF Offerings With Three New Funds</a>
"With over $80 million in client inflows, it's clear that investors look to Thornburg's four decades of investing excellence and prudent risk management to achieve their long-term financial goals," said Mark Zinkula, CEO of Thornburg Investment Management. "Expanding our ETF lineup with two fixed-income ETFs reflects our commitment to meeting long-term client demand."
<h3 class="wp-block-heading">Disciplined Investment With TPLS</h3>
The Thornburg Core Plus Bond ETF is designed to provide income and capital appreciation with flexibility to invest in a broad range of bonds and related instruments. The net expense ratio of 45 basis points.
Up to 25% of the ETF&#8217;s net assets can be allocated to high-yield bonds, offering the potential for higher income and diversification.
<h3 class="wp-block-heading">Expanding Sector Exposure With TMB</h3>
The Thornburg Multi Sector Bond ETF is ideal for investors seeking broader exposure to fixed-income markets. With a net expense ratio of 0.55%, TMB invests in various fixed-income securities, including mortgage-backed securities, structured notes, bank loans, and zero-coupon bonds.
Like TPLS, it seeks to generate both income and capital appreciation. It does so through a more extensive selection of fixed-income assets.
As demand for actively managed bond funds grows, Thornburg's latest ETFs provide additional tools for portfolio diversification and income generation. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43534399/schwab-expands-active-fixed-income-lineup-with-new-core-bond-etf">Schwab Expands Active Fixed Income Lineup With New Core Bond ETF</a></li>
</ul>
Photo: Shutterstock

New ETFs

ETFs

TPLS

TXUE

TXUG

Thornburg's New Bond ETF Launches: A Peek Into TPLS And TMB

New York lawmakers have introduced a <a href="https://www.nysenate.gov/legislation/bills/2025/S3600">bill</a> aimed at decriminalizing the possession of controlled substances, a move that could reshape drug policy in the state. Senate Bill S3600, sponsored by State Senator Gustavo Rivera (D-WF, 33rd District), seeks to eliminate criminal and civil penalties for personal drug possession, prioritizing public health over punishment. The bill also proposes the creation of a Drug Decriminalization Task Force to develop further recommendations for reforming laws and regulations related to drug use and substance use disorder (SUD).
<h3 class="wp-block-heading">A Paradigm Shift In Drug Policy</h3>
If enacted, S3600 would repeal key sections of New York's penal code that criminalize drug possession. It would expunge past convictions and ensure that individuals on parole, probation or awaiting trial are not penalized for conduct that is no longer criminal under the new law. Instead of facing misdemeanor charges, individuals caught with small amounts of controlled substances would receive a fine of up to $50 or be referred to a screening for social services, including substance use treatment, housing assistance or mental health support.
"The purpose of this legislation is to save lives and to help transform New York's approach to drug use from one based on criminalization and stigma to one based on science and compassion," the bill states.
<h3 class="wp-block-heading">Case For Decriminalization</h3>
New York's move follows a growing global trend of drug decriminalization policies aimed at reducing incarceration rates and promoting harm reduction. Portugal, which decriminalized drug possession in 2001, saw a <a href="https://www.unaids.org/en/resources/presscentre/featurestories/2020/march/20200303_drugs">dramatic drop</a> in overdose deaths and HIV infections among people who use drugs. Other countries, including the <a href="https://globalinitiative.net/wp-content/uploads/2017/12/GCDP-Report-2016-ENGLISH.pdf">Netherlands</a>, <a href="https://www.unodc.org/documents/ungass2016/Contributions/Civil/DrugPolicyAlliance/DPA_Fact_Sheet_Approaches_to_Decriminalization_Feb2015_1.pdf">Argentina</a>, Colombia and <a href="https://www.wola.org/sites/default/files/Drug%20Policy/IDPC-briefing-paper_Drug-policy-reform-in-Latin-America_V2_ENGLISH.pdf">Mexico</a>, have adopted similar models.
In the United States, <a href="https://www.npr.org/2021/06/18/1007022652/oregons-pioneering-drug-decriminalization-experiment-is-now-facing-the-hard-test">Oregon</a> became the first state to decriminalize all drugs in 2020, passing Measure 110, which redirected law enforcement funding toward treatment and harm reduction services. While Oregon's policy has faced scrutiny over implementation challenges, advocates argue that it is still a step in the right direction, away from the failed War on Drugs.
<h3 class="wp-block-heading">Role Of Drug Decriminalization Task Force</h3>
A key component of New York's bill is the establishment of a Drug Decriminalization Task Force, which would be responsible for analyzing drug use trends, identifying effective public health strategies and proposing additional legal reforms. The task force would examine:
<ul>
<li>The quantities of drugs considered consistent with personal use.</li>
<li>The barriers people with SUD face in accessing treatment.</li>
<li>How to mitigate the collateral consequences of drug-related convictions, such as restrictions on employment, housing and education.</li>
</ul>
The bill explicitly addresses racial disparities in drug law enforcement, acknowledging that Black and Latinx communities have historically been disproportionately affected by drug-related arrests and incarceration rates.
<h3 class="wp-block-heading">Public Health vs. Criminalization</h3>
The shift toward decriminalization aligns with the growing consensus among health experts that SUD is a medical condition, not a moral failing. The National Institute on Drug Abuse (NIDA) describes substance use disorder as "a chronic, relapsing disorder that leads to lasting changes in the brain, characterized by compulsive drug-seeking behavior." Research suggests that punitive drug policies have done little to deter drug use but have exacerbated the stigma and barriers to care for those struggling with addiction.
Advocates argue that treating drug use as a health issue rather than a crime would not only reduce incarceration rates but also help curb overdose deaths, lower HIV and hepatitis transmission rates and improve access to treatment.
<h3 class="wp-block-heading">Potential Challenges And Criticism</h3>
Despite its ambitious goals, S3600 is likely to face opposition from law enforcement groups as well as some policymakers and concerned citizens who fear decriminalization could lead to increased drug use and public safety issues. Critics point to Oregon's initial struggles with Measure 110, where a lack of treatment infrastructure and public confusion about the law's implementation slowed its impact.
However, supporters argue that New York can learn from Oregon's challenges by ensuring adequate investment in treatment services before fully implementing decriminalization.
<h3 class="wp-block-heading">What Comes Next?</h3>
Senate Bill S3600 is now under review in the Senate Codes Committee. If it advances, the next steps include:
<ul>
<li>On Floor Calendar Assembly</li>
<li>On Floor Calendar Senate</li>
<li>Passed Assembly</li>
<li>Passed Senate</li>
<li>Delivered to Governor</li>
<li>Signed By Governor</li>
</ul>
If the bill successfully navigates these steps, it would mark a significant shift in how New York addresses drug use and substance dependency. As New York debates the merits of decriminalization, one thing is clear: the conversation around drug policy is shifting, and with it the potential for a more health-focused, harm-reduction-driven approach to addressing substance use.
Photo via Shutterstock

Cannabis

Politics

Inside New York's Bold Plan To Decriminalize Drug Possession

Trading Ideas

SGBX

Safe & Green Holdings Shares Resume Trade

Macro Economic Events

News

Global

Econ #s

Economics

Bank of Mexico Cuts Overnight Rate 50 Bps To 9.50%

LYFT

Lyft shares are trading higher after the company announced it will work with Anthropic to create new Lyft products to change the rideshare experience.

Cloudflare Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) will be reporting its fourth-quarter earnings on Thursday. Wall Street expects 18 cents in EPS and $452.10 million in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=NET" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is up 73.71% over the past year, 25.94% YTD.
Let&#8217;s look at what the charts indicate for Cloudflare stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/25/02/43441666/cloudflare-introduces-one-click-tool-to-combat-deepfakes-and-misinformation">Cloudflare Introduces One-Click Tool To Combat Image Deepfakes And Misinformation</a>
<h1 class="wp-block-heading">Cloudflare Stock Strongly Bullish Ahead of Q4 Earnings</h1>
Cloudflare stock is exhibiting strong bullish momentum ahead of its fourth-quarter earnings report, with the stock trading above key moving averages. The share price of $144.29 is comfortably above its five-day, 20-day and 50-day exponential moving averages, indicating sustained buying pressure. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="626" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06122515/Screenshot-2025-02-06-at-7.55.14-PM.png" alt="" class="wp-image-769998" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06122515/Screenshot-2025-02-06-at-7.55.14-PM.png 626w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06122515/Screenshot-2025-02-06-at-7.55.14-PM-300x235.png 300w" sizes="(max-width: 626px) 100vw, 626px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020625&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
The eight-day simple moving average at $137.48 reinforces the bullish trend, while Cloudflare stock&#8217;s position above its 20-day ($125.15), 50-day ($115.93) and 200-day ($90.08) simple moving averages signals strength across all time frames.
For investors, the technical setup suggests continued upside potential if earnings align with or exceed expectations. The Moving Average Convergence Divergence (MACD) indicator at 8.02 supports strong momentum, but the Relative Strength Index (RSI) at 78.13 places Cloudflare in overbought territory. This could introduce short-term volatility, with the potential for profit-taking. 
A strong earnings beat could propel the stock higher, while a miss may test support levels around $125–$115. Traders should watch for potential pullbacks, but the broader trend remains bullish.
<h1 class="wp-block-heading">Cloudflare Analysts See Limited Upside</h1>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/NET/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Cloudflare stock stands at a Buy currently with a price target of $111.46. The latest analyst ratings from Needham, Baird and Truist Securities imply a 3.67% upside for Cloudflare, with a $146.67 price target.
NET Stock Price Action: Cloudflare stock was trading at $141.53 at the time of publication Thursday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/insights/news/25/01/43323329/1000-invested-in-this-stock-5-years-ago-would-be-worth-this-much-today">$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today</a></li>
</ul>

Technicals

Previews

Tech

Cloudflare's Technicals Look Strong: Will Q4 Earnings Justify Hype?

Safe & Green Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 42%

ASGN

ASGN shares are trading lower after the company reported worse-than-expected Q4 revenue results and issued Q1 guidance below estimates.

REYN

Reynolds Consumer Products shares are trading lower after multiple firms cut their respective price targets on the stock.

Online dating apps have struggled amid <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42912846/match-group-bumbles-growth-stalls-analyst-warns-challenging-2025">lulls in growth</a> and user frustration with the services. Amid a change in leadership at Match Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>), two analysts have mixed feelings about the Dallas-based company&#8217;s prospects in 2025.
The Match Group Analysts: On Wednesday, the following analysts released notes on Match Group&#8217;s fourth-quarter earnings:
<ul>
<li>Goldman Sachs analyst Eric Sheridan reiterated a Buy rating, lowering its price target from $40 to $39.</li>
<li>JPMorgan analyst Cory A. Carpenter reiterated a Neutral rating with a $33 price target.</li>
</ul>
See Also: <a href="https://www.benzinga.com/25/02/43540571/trump-media-shares-are-trading-higher-today-whats-going-on">Trump Media Shares Are Trading Higher, Here&#8217;s Why</a>
Goldman Sachs: Sheridan noted the company&#8217;s commentary during earnings.
&#8220;While the stock has reacted negatively to these results, we came away with the conclusion that the company was more focused on timing narratives within 2025 and the impact of f/x rather than any wholesale shifts in strategy or operating priorities,&#8221; the analyst said.
Sheridan says the earnings report highlighted stable trends at Tinder and momentum at Hinge, both subsidiaries of the company. 
Match Group also owns OkCupid and Match.com. 
The analyst remains focused on new CEO Spencer Rascoff and new CFO Steven Bailey. Their operational strategy going forward is currently unclear. Still, Sheridan is encouraged by positive commentary on Tinder and the focus on expansion into Mexico and Brazil.
JPMorgan: Carpenter noted the change in leadership at the company.
&#8220;MTCH also delivered a surprise in the CEO transition from BK to Spencer Rascoff, which creates some near-term uncertainty but we think is likely to be well received over time,&#8221; the analyst said.
Carpenter is encouraged by positive results for Tinder within the quarter, but noted that &#8220;revenue acceleration could be tough in a challenged dating market.&#8221;
Price Action: Shares of Match Group fell nearly 8% on Wednesday following the earnings announcement. The stock rebounded 2.14% on Thursday, rising to $34.30.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/02/43525518/eli-lilly-q4-earnings-strong-demand-for-mounjaro-but-prices-dip-forecasts-over-30-jump-in-2025-sales-on-newer-medicines">Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines</a></li>
</ul>
Image: Shutterstock

Earnings

Equities

Price Target

Reiteration

Analyst Ratings

MTCH

Match Group Divides Analysts Following Earnings: New Management 'Likely To Be Well Received'

<a target="_blank" href="https://www.benzinga.com/topic/semiconductor" rel="noreferrer noopener">Semiconductor equipment companies</a> ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>), Applied Materials, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), KLA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>), and Lam Research Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) became significant beneficiaries of the artificial intelligence boom, bearing testimony to the interconnectivity of the industry ecosystem.
Recently, CNBC&#8217;s Jim Cramer flagged how the <a target="_blank" href="https://www.benzinga.com/25/01/43138590/jim-cramer-says-taiwan-semiconductors-capex-plans-boost-applied-materials-lam-research-kla-stocks" rel="noreferrer noopener">capital equipment companies</a> got a boost from the &nbsp;Taiwan Semiconductor Manufacturing Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) upbeat quarterly print and guidance.
It has committed $38 billion—$42 billion in fiscal 2025 capex versus the actual fiscal 2024 capex of $29.8 billion, including a boost of capex on equipment triggering a rally in its supplier stocks, including&nbsp;Applied Materials,&nbsp;Lam Research, and&nbsp;KLA, Cramer inferred.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43532222/entegris-q4-earnings-revenue-and-profit-beat-warns-of-2025-uncertainty-beyond-ai-growth" rel="noreferrer noopener">Entegris Q4 Earnings: Revenue And Profit Beat, Warns of 2025 Uncertainty Beyond AI Growth</a>
The contract chipmaker reported&nbsp;fourth-quarter revenue&nbsp;of $26.88 billion, up by 39%, topping the consensus of $26.28 billion. The company expects first-quarter revenue of $25.0 billion—$25.8 billion, compared to the&nbsp;$24.97 billion consensus.
Cramer correlated advanced process technologies with equipment catering to&nbsp;Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) GPUs and other accelerators.
ASML Holding, a $292 billion company, trades at a PE multiple of 37.2x versus Applied Materials&#8217; ($147 billion market cap) 18.8x, Lam Research&#8217;s ($105 billion market cap) 21.5x and KLA&#8217;s ($101 billion market cap) 24.2x.
The cash-rich chip equipment makers have consistently paid dividends, with a dividend yield of ~1%.
ASML Holdings&#8217; gross margin is 51.7%, compared to Applied Materials&#8217; 47.3%, KLA&#8217;s 60.30%, and Lam Research&#8217;s 47.4%.
Applied Materials analysts had flagged the impact of intensifying geopolitical tensions between the U.S. and China, considering the company&#8217;s significant <a target="_blank" href="https://www.benzinga.com/news/earnings/earnings-beats/24/11/42015379/applied-materials-reports-solid-q4-beat-analysts-express-concern-around-high-exposure-to-china-spending-decline" rel="noreferrer noopener">exposure to the country</a>.
The U.S. is already ASML Holding&#8217;s largest market, overtaking China in <a target="_blank" href="https://www.benzinga.com/25/01/43301092/us-surpasses-china-as-chip-equipment-maker-nvidia-supplier-asmls-biggest-market-in-q4" rel="noreferrer noopener">the fourth quarter</a>. Applied Materials and Lam Research have contacted non-Chinese suppliers to <a target="_blank" href="https://www.benzinga.com/government/24/11/41726213/applied-materials-and-lam-research-shift-supply-chains-away-from-china-to-meet-new-us-guidelines" rel="noreferrer noopener">comply with regulations</a>.
Goldman Sachs analyst Toshiya Hari&nbsp;expects Lam Research to outperform its <a target="_blank" href="https://www.benzinga.com/25/01/42924519/nvidia-amd-broadcom-lead-semiconductor-stock-decline-amid-us-china-ai-chip-export-ban-concerns-amd-downgraded-by-goldman-sachs-and-more" rel="noreferrer noopener">immediate peers in 2025</a>.
In addition to a quarterly recovery in the overall Wafer Fab Equipment market, he expects distinctive drivers like the adoption of Gate-All-Around transistors in leading-edge Foundry or Logic and the resumption of technology transitions in 3D NAND to support revenue growth that exceeds the overall WFE market.&nbsp;
Global sales of total semiconductor manufacturing equipment&nbsp;by original equipment manufacturers (OEMs) will likely reach $113 billion in 2024, up by 6.5%, according to <a target="_blank" href="https://www.semi.org/en/semi-press-release/global-total-semiconductor-equipment-sales-forecast-to-reach-a-record-of-dollar-139-billion-in-2026-semi-reports" rel="noreferrer noopener">SEMI</a>. Semiconductor manufacturing equipment growth will likely reach $121 billion in 2025 and $139 billion in 2026.&nbsp;
Rising demand for advanced chips in devices like smartphones, PCs, and IoT gadgets fueled the growth, according to <a target="_blank" href="https://www.globenewswire.com/news-release/2025/01/07/3005364/0/en/Semiconductor-Equipment-Market-to-Worth-USD-254-Billion-by-2032-Driven-By-Advanced-Technologies-and-Growth-in-Various-Industries-Research-by-SNS-Insider.html#:~:text=A%20key%20market%20driver%20for,%2C%20AI%2C%20and%20autonomous%20vehicles." rel="noreferrer noopener">SNS Insider</a>.
Countries have also poured in money to stay ahead in the semiconductor race. Major countries, including the U.S., Japan, China, and Europe, initiated the U.S. CHIPS and Science Act, Japan&#8217;s ¥1 trillion R&amp;D investment, China&#8217;s Made in China 2025 strategy, and the European Chips Act to boost local semiconductor production.&nbsp;
According to SEMI, China, Taiwan, and Korea will likely remain the top three destinations&nbsp;for equipment spending through 2026.&nbsp;
MSCI World Semiconductors &amp; Semiconductor Equipment Index yielded a 37% return in the last 12 months. It trades at a PE multiple of 48.7x. S&amp;P Semiconductors Select Industry Index yielded over 19% in the same time frame.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/43442424/meta-outspends-apple-and-amazon-on-arvr-betting-big-on-future-of-smart-glasses-and-ai" target="_blank" rel="noreferrer noopener">Meta Bets Big on Future of Smart Glasses and AI, Outspends Apple and Amazon on AR/VR</a></li>
</ul>
Image Via Shutterstock

AMAT

ASML

KLAC

LRCX

NVDA

Chip Equipment Stocks Gain Traction as AI Demand, TSMC's Capex, and Semiconductor Expansion Drive Valuations

Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $190.9, a high estimate of $250.00, and a low estimate of $160.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.38%. 
<img src="https://www.benzinga.com/files/images/story/2025/1738868464_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Qualcomm. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Lipacis</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$179.00</td>
<td>$199.00</td>
</tr>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Harsh Kumar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Kevin Cassidy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$250.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$185.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$215.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Ben Reitzes</td>
<td>Melius Research</td>
<td>Announces</td>
<td>Hold</td>
<td>$180.00</td>
<td>-</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$210.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>C J Muse</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Gary Mobley</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Hold</td>
<td>$180.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Qualcomm. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Qualcomm compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Qualcomm's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Qualcomm's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/QCOM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Qualcomm analyst ratings.</a>
<h2>Get to Know Qualcomm Better</h2>
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
<h3>A Deep Dive into Qualcomm's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Qualcomm displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 18.69%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Qualcomm's net margin excels beyond industry benchmarks, reaching 28.5%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Qualcomm's ROE stands out, surpassing industry averages. With an impressive ROE of 11.46%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Qualcomm's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.41% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Qualcomm's debt-to-equity ratio stands notably higher than the industry average, reaching 0.56. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

QCOM

10 Analysts Assess Qualcomm: What You Need To Know

In the preceding three months, 19 analysts have released ratings for Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">12</td>
<td align="right">3</td>
<td align="right">2</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $79.95, a high estimate of $105.00, and a low estimate of $60.00. This current average represents a 21.06% decrease from the previous average price target of $101.28. 
<img src="https://www.benzinga.com/files/images/story/2025/1738868453_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Skyworks Solutions. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toshiya Hari</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Ruben Roy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$62.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Joseph Moore</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$72.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Harsh Kumar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Kevin Cassidy</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$60.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Craig Ellis</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$65.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$62.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$70.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Sell</td>
<td>$84.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Sell</td>
<td>$72.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Harsh Kumar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$85.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Anthony Stoss</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Buy</td>
<td>$105.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$80.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Peter Peng</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Joseph Moore</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$87.00</td>
<td>$117.00</td>
</tr>
<tr>
<td>Gary Mobley</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Hold</td>
<td>$90.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Skyworks Solutions. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Skyworks Solutions compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Skyworks Solutions's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Skyworks Solutions's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SWKS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Skyworks Solutions analyst ratings.</a>
<h2>Unveiling the Story Behind Skyworks Solutions</h2>
Skyworks Solutions Inc produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
<h3>Key Indicators: Skyworks Solutions's Financial Health</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining Skyworks Solutions's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -15.9% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 5.9%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 0.95%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.73%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Skyworks Solutions's debt-to-equity ratio is below the industry average at 0.19, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SWKS

Deep Dive Into Skyworks Solutions Stock: Analyst Perspectives (19 Ratings)

In the preceding three months, 6 analysts have released ratings for NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $18.0, along with a high estimate of $22.00 and a low estimate of $12.00. Experiencing a 10.0% decline, the current average is now lower than the previous average price target of $20.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1738868445_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive NOV is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Rollyson</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>James West</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$18.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$12.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Waqar Syed</td>
<td>ATB Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$19.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NOV. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NOV compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of NOV's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of NOV's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/NOV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on NOV analyst ratings.</a>
<h2>About NOV</h2>
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
<h3>NOV: Financial Performance Dissected</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: NOV's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 0.27%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: NOV's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 5.93%, the company may face hurdles in effective cost management.
Return on Equity (ROE): NOV's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.02%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): NOV's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.14%, the company may face hurdles in achieving optimal financial returns.
Debt Management: NOV's debt-to-equity ratio is below the industry average at 0.37, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying NOV: Insights From 6 Analyst Reviews

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $162.75, a high estimate of $175.00, and a low estimate of $155.00. This current average has decreased by 0.36% from the previous average price target of $163.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1738868434_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Ensign Group's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Raj Kumar</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$155.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Tao Qiu</td>
<td>Macquarie</td>
<td>Raises</td>
<td>Outperform</td>
<td>$166.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$155.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>A.J. Rice</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$175.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ensign Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Ensign Group compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Ensign Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ensign Group's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ENSG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ensign Group analyst ratings.</a>
<h2>Unveiling the Story Behind Ensign Group</h2>
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
<h3>Key Indicators: Ensign Group's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Ensign Group's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 14.99%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Ensign Group's net margin excels beyond industry benchmarks, reaching 7.25%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ensign Group's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.61% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Ensign Group's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.73% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Ensign Group's debt-to-equity ratio is below the industry average. With a ratio of 1.15, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ENSG

4 Analysts Assess Ensign Group: What You Need To Know

4 analysts have shared their evaluations of Griffon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFF#NYSE">GFF</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $100.0, with a high estimate of $105.00 and a low estimate of $95.00. This upward trend is evident, with the current average reflecting a 8.4% increase from the previous average price target of $92.25.
<img src="https://www.benzinga.com/files/images/story/2025/1738868427_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Griffon's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sam Darkatsh</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$95.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Trey Grooms</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Timothy Wojs</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Trey Grooms</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$85.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Griffon. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Griffon compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Griffon's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Griffon's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/GFF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Griffon analyst ratings.</a>
<h2>Unveiling the Story Behind Griffon</h2>
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.
<h3>Griffon: Financial Performance Dissected</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Griffon's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 2.85%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Griffon's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 9.47%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 27.87%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 2.63%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Griffon's debt-to-equity ratio is notably higher than the industry average. With a ratio of 7.59, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Have This To Say About Griffon

Ratings for LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $401.27, along with a high estimate of $435.00 and a low estimate of $378.00. This upward trend is apparent, with the current average reflecting a 13.06% increase from the previous average price target of $354.93.
<img src="https://www.benzinga.com/files/images/story/2025/1738868414_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of LPL Finl Hldgs among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$413.00</td>
<td>$379.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$420.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Michael Cho</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$405.00</td>
<td>$397.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$405.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$435.00</td>
<td>$435.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$405.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$414.00</td>
<td>$389.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$379.00</td>
<td>$378.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$385.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Michael Cho</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$397.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$390.00</td>
<td>-</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$390.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$413.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$390.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$378.00</td>
<td>$311.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to LPL Finl Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of LPL Finl Hldgs compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for LPL Finl Hldgs's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into LPL Finl Hldgs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LPLA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on LPL Finl Hldgs analyst ratings.</a>
<h2>Delving into LPL Finl Hldgs's Background</h2>
LPL Financial Holdings is an independent broker/dealer that provides a platform of proprietary technology, brokerage, and investment advisory services to financial advisors and institutions. As of the end of September 2024, the company had over 23,000 advisors on its platform managing $1.6 trillion of client assets. The company doesn't have material operations outside of the United States.
<h3>LPL Finl Hldgs: A Financial Overview</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining LPL Finl Hldgs's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.0% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: LPL Finl Hldgs's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 7.71%, the company may face hurdles in effective cost management.
Return on Equity (ROE): LPL Finl Hldgs's ROE excels beyond industry benchmarks, reaching 9.5%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): LPL Finl Hldgs's ROA excels beyond industry benchmarks, reaching 2.14%. This signifies efficient management of assets and strong financial health.
Debt Management: LPL Finl Hldgs's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.87.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LPLA

Deep Dive Into LPL Finl Hldgs Stock: Analyst Perspectives (15 Ratings)

Nuix

Comments

Nuix

News

Latest news for Nuix (OTC:NXLLF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga